Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

Biochemistry, Genetics and Molecular Biology

• Taxon 100%
• Gut Microbiome 100%
• Dysbiosis 100%
• Metabolic Pathway 33%
• Gene Sequence 33%
• Phytochemical 33%
• Intestine Flora 33%
• Microbiome 33%
• 16S Ribosomal RNA 33%
• O-Methyltransferase 33%
• Anticholinergic 33%
• Lachnospiraceae 33%
• Pasteurellaceae 33%
• Lactobacillaceae 33%
• Bifidobacteriaceae 33%
• Grand Unified Theory 33%
• Carbidopa 33%

Keyphrases

• Parkinson's Disease 100%
• Gut Microbiota 100%
• Functional Pathways 30%
• Potential Confounders 20%
• Microbial Composition 20%
• Dysbiosis 20%
• United States 10%
• Disease Case 10%
• Statistical Analysis 10%
• Metabolism 10%
• Gastrointestinal Diseases 10%
• Multiple Testing 10%
• Stool 10%
• 16S rRNA Gene Sequencing 10%
• Gut Diseases 10%
• Fruit Vegetables 10%
• Catechol-O-methyltransferase Inhibitors 10%
• Microbiome 10%
• Testable Hypothesis 10%
• New Leads 10%
• Functional Prediction 10%
• Gut Dysbiosis 10%
• Lachnospiraceae 10%
• Lactobacillaceae 10%
• Xenobiotic Degradation 10%
• Pasteurellaceae 10%
• Taxa Abundance 10%
• Microbial Signatures 10%
• Compound Degradation 10%
• Verrucomicrobiaceae 10%
• Bifidobacteriaceae 10%
• Christensenellaceae 10%
• Levodopa/carbidopa 10%
• Region of Residence 10%
• Patient-independent 10%
• Plant-derived Compounds 10%

Immunology and Microbiology

• Christensenellaceae 10%